BioTechGrid

CARsgen Therapeutics’ CAR-T improved progression-free survival (PFS) compared to approved therapies for patients with advanced stomach cancer in a phase…

A recent breakthrough in cancer research has unveiled significant insights into the mechanisms of clear cell renal cell carcinoma (ccRCC),…

Hula hooping has long been seen as a playful activity, often associated with childhood and leisure. However, beneath this seemingly…

Recent research has illuminated the potential benefits of psilocybin, a naturally occurring compound found in certain species of psychedelic mushrooms,…

A recent groundbreaking study published in the esteemed journal Nature Medicine has emerged from the innovative research team at Karolinska…

Neumora Therapeutics’ big bet on a new era of neuroscience has delivered an age-old result. The first of three late-stage…

Valo Health’s Rho kinase (ROCK) 1 and 2 inhibitor has failed to reduce the severity of diabetic retinopathy in a phase 2 trial, leading…

Dealmakers at BeiGene, Brii Biosciences and Ideaya Biosciences had a busy end to the year, sharing news of agreements for…

Cash-strapped Viracta Therapeutics is continuing to reduce its options in order to stay afloat. Less than two months after announcing…

Pfizer gave Sangamo Therapeutics coal for Christmas, terminating a hemophilia A gene therapy pact to deprive the cash-strapped biotech of up…